Breaking News

KitoZyme Lands More Funding

April 4, 2013

• KitoZyme has finalized a €9 million capital increase. The issue of new shares was reserved for and entirely underwritten by the company’s two main shareholders: Valois (Mestdagh Group and Montulet family) and SRIW, the Wallonia Regional Investment Company.

The move will significantly build the company’s equity and will allow it to actively continue developing new products and its international commercial expansion, according to company executives.
Based in Liège, Belgium, the company is active in the biochemistry and life sciences sectors, manufacturing biomass-derived biopolymers, non-animal chitosan, chitin-glucan and beta-glucan.
blog comments powered by Disqus